menu ☰
menu ˟

Gene therapy shows promise for patients with chronic SCID-X1

05 Dec 2015
ORLANDO, Fla. — Lentiviral hematopoietic stem cell gene therapy with reduced-intensity conditioning produced pan-immunologic correction of T, B and natural killer cells in the bone marrow of older patients with X-linked severe combined immunodefici...

Click here to view the full article which appeared in Hematology Oncology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.